Show results for
  • Sygnature
  • News
  • Drug Discovery
  • Therapeutic Areas
  • Events
  • Vacancies

Dr Jonathan Williams

Jonathan joined the company as a laboratory scientist in November 2004 and was promoted to the Board in October 2008.

Prior to Sygnature, Jonathan had already gained 13 years of drug discovery experience – eight years in the Medicinal Chemistry Department at OSI Pharmaceuticals, and five years working within a contract research environment at Aston Molecules. As well as being a member of the Board of Directors, one of Jonathan’s key roles as COO is to ensure that the necessary resources and controls are in place to enable the organization to operate and continue to grow efficiently and effectively.

Jonathan has a BA in Chemistry from the University of Oxford and a PhD in organic chemistry from the University of Manchester.